A 58-year-old man with a history of chronic obstructive pulmonary disease (COPD) presents to the emergency department with acute dyspnea and wheezing. His blood pressure is 95/60 mmHg, heart rate 110 bpm, and SpO₂ 88% on room air. Physical examination reveals severe bronchospasm. After initial oxygen therapy and nebulized salbutamol, his condition does not improve. The physician decides to administer intravenous epinephrine. Which of the following best explains the rationale for using epinephrine in this acute setting rather than a selective β₂-agonist alone?

Explanation

## Clinical Context This is an acute, life-threatening bronchospasm with hemodynamic compromise (hypotension). While selective β₂-agonists (like salbutamol) are first-line for bronchospasm, this patient's hypotension and inadequate response necessitate a mixed α- and β-adrenergic agonist. ## Mechanism of Epinephrine in Acute Bronchospasm with Hypotension **Key Point:** Epinephrine is a non-selective adrenergic agonist with dose-dependent effects: - At **low doses** (0.5–2 μg/min IV): predominantly β-adrenergic effects (β₂-mediated bronchodilation, β₁-mediated increased cardiac output) - At **higher doses** (2–10 μg/min IV): α₁-adrenergic effects dominate, causing vasoconstriction and increased systemic vascular resistance **High-Yield:** In this hypotensive patient, epinephrine's **α₁-mediated peripheral vasoconstriction** restores blood pressure while its **β₂-activity** relieves bronchospasm. This dual action addresses both the airway obstruction and the cardiovascular collapse simultaneously. ## Why Epinephrine Over Selective β₂-Agonists? | Feature | Selective β₂-Agonist (Salbutamol) | Epinephrine | |---------|-----------------------------------|-------------| | Bronchodilation | ✓ (via β₂) | ✓ (via β₂) | | Systemic hypotension | May worsen (peripheral vasodilation) | Corrected (via α₁ vasoconstriction) | | Cardiac output | Minimal effect | Increased (via β₁) | | Use in shock | Contraindicated | Indicated | **Clinical Pearl:** The combination of severe bronchospasm + hypotension is a classic indication for IV epinephrine (not IM, which is reserved for anaphylaxis). The α₁-mediated vasoconstriction maintains coronary and cerebral perfusion pressure, which is critical in this decompensated state. ## Dosing in Acute Bronchospasm with Shock 1. Start at 2–5 μg/min IV infusion 2. Titrate to blood pressure response (target SBP >90 mmHg) 3. Monitor for tachycardia and arrhythmias [cite:KD Tripathi 8e Ch 11]